Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 47 resultados

ViroiDoc: Advanced Research on Viroid Pathogenesis and Control for Agricultural Sustainability ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Viroids, the smallest infectious pathogens, cause crop losses in the millions of euros every year and affect crop yields and quality worldwi...
2024-07-10 - 2028-12-31 | Financiado

EU PAL-COPD: Evaluation of the ICLEAR-EU intervention to integrate palliative care in the treatment of people wit... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Chronic Obstructive Pulmonary Disease (COPD) is a devastating life-limiting lung disease with a high personal and societal burden. Worldwide...
2023-12-08 - 2028-12-31 | Financiado

GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatia... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "Adult and paediatric malignant glioma (GBM and pHGG) remain among the most difficult-to-treat cancers with 5-year survival rates of <5% des...
2023-12-07 - 2028-12-31 | Financiado

PIONEAR: A photonic microphone with better-than-human-ear sound quality ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 Microphones play an increasingly important role in how we communicate and perceive the world in our ever more digital and virtual lives. The...
2023-12-05 - 2028-01-31 | Financiado

EDiHTA: The first European Digital Health Technology Assessment framework co-created by all stakeholders alo... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 Digital health technologies (DHTs) are expected to improve both the quality and delivery of healthcare services for European societies while...
2023-11-28 - 2027-12-31 | Financiado

DarChemDN: Darwinian Chemistry Doctoral Network ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Darwinian evolution is unrivalled in its ability to invent, which Humankind has already exploited for various purposes such as plant and ani...
2023-07-06 - 2027-10-31 | Financiado

ThermoBreast: An innovative non-contact and harmless screening modality set to change the course of breast cancer... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 Female breast cancer is the most diagnosed cancer worldwide. In 2020, the International Agency for Research on Cancer estimated more than 2....
2022-11-28 - 2026-12-31 | Financiado

PEPPERONI: Pilot line for European Production of PEROvskite Silicon taNdem modules on Industrial scale ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-CL5-2021-D3-03 To prevent the worst outcomes of climate change and increase Europe’s energy independence, urgent and massive efforts are required to transf...
2022-10-20 - 2026-10-31 | Financiado

SOLARX: Dispatchable concentrated Solar to X energy solution for high penetration of renewable energy ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-CL5-2021-D3-03 Current energetic infrastructures are inefficient and hardly capable of integrating a large share of intermittent renewable energy sources....
2022-10-20 - 2025-10-31 | Financiado

DIGI PLUS: Leadership for Sustainable Digital Transformation in Europe ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 DIGI+ is a world-class research fellowship programme, cofunded by MSCA, on Sustainable Digital Transformation that aims for a new generation...
2022-09-29 - 2028-12-31 | Financiado

BREAKthrough: Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria throu... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Antimicrobial resistance, which is caused by multi-drug-resistant bacterial pathogens is a global health emergency. Gram-negative bacteria (...
2022-07-14 - 2026-12-31 | Financiado

SYNSENSO: Cell-free synthetic biology for combinatorial biosensor design ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Recent advances in the field of synthetic biology offer an unprecedented opportunity for next-generation biosensors characterized by program...
2022-07-13 - 2026-08-31 | Financiado

ROADVIEW: Robust Automated Driving in Extreme Weather ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-CL5-2021-D6-01 Complex environment and traffic conditions have major impact on the safety and operations of Connected and Automated Vehicles (CAVs). Weathe...
2022-06-09 - 2026-08-31 | Financiado

MyPath: Developing and implementing innovative Patient Centred Care Pathways for cancer patients ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in earl...
2022-05-20 - 2027-08-31 | Financiado

GENEGUT: Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Crohn’s disease is a non-communicable, global disease with an accelerating incidence (up to 23 per 100,000 persons/year) and annual health c...
2022-05-19 - 2026-09-30 | Financiado

CORENET: Complex chemical reaction networks for breakthrough scalable reservoir computing ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDEROPEN-01 The brain is the world’s most amazing computer and it runs entirely on chemical reactions. The vision of CORENET is to construct brain-mimic...
2022-02-02 - 2026-03-31 | Financiado

COVend: Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stag... ACCELOPMENT SCHWEIZ AG participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 More than 2.7 million hospitalisations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in...
2021-11-12 - 2025-01-31 | Financiado

DECIDE: Data driven control and prioritisation of non EU regulated contagious animal diseases ACCELOPMENT SCHWEIZ AG participó en un H2020: H2020-SFS-2018-2020 Farmers, veterinarians and other animal health managers in the livestock sector are currently missing information on prevalence and burden o...
2021-05-07 - 2026-06-30 | Financiado

AI-Mind: Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people... More than 10 million Europeans show signs of mild cognitive impairment (MCI), a condition intermediate between normal brain ageing and demen...
2021-01-18 - 2026-02-28 | Financiado

PHOTONFOOD: FLEXIBLE MID INFRARED PHOTONIC SOLUTIONS FOR RAPID FARM TO FORK SENSING OF FOOD CONTAMINANTS ACCELOPMENT SCHWEIZ AG participó en un H2020: H2020-ICT-2018-20 Analytical techniques for the measurements of chemical and microbial contaminations along the food chain require detection levels in the ppb...
2020-12-07 - 2024-12-31 | Financiado

accelCH